0 NASDAQ Companies - March 14, 2024Karat Packaging Reports Fourth Quarter and Full Year 2023 Financial ResultsCHINO, Calif., March 14, 2024 (GLOBE NEWSWIRE) — Karat Packaging Inc. (Nasdaq: KRT) (“Karat” or the “Company”), a specialty distributor […]Read More
0 NASDAQ Companies - March 14, 2024Brilliant Earth Reports Fourth Quarter and Fiscal Year 2023 ResultsGrowth Rate Exceeded the Industry by an Estimated 750 bps in 2023Exceeded Profitability Expectations and Increased 2023 Gross Margin by […]Read More
0 NASDAQ Companies - March 14, 2024Xcel Brands, Inc. Announces Proposed Public Offering of Common StockNEW YORK, March 14, 2024 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (“Xcel”; NASDAQ: XELB), a media and consumer products company […]Read More
0 NASDAQ Companies - March 14, 2024Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsFiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in […]Read More
0 NASDAQ Companies - March 14, 2024Kandi Technologies Reports 2023 Financial ResultsJINHUA, China, March 14, 2024 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company”, “we” or “Kandi”) (NASDAQ GS: KNDI), […]Read More
0 NASDAQ Companies - March 14, 2024Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common StockPURCHASE, N.Y., March 14, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical […]Read More
0 NASDAQ Companies - March 14, 2024Rigetti Computing Reports Fourth Quarter and Full Year 2023 ResultsDeployed the 84-qubit Ankaa™-2 quantum computer, with a 2.5X improvement in error performance compared to the Company’s previous QPUs and […]Read More
0 NASDAQ Companies - March 14, 2024Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdatesInterim data from initial dose escalation cohorts from Phase 1 trial of TERN-701 (allosteric BCR-ABL) for treatment of CML expected […]Read More
0 NASDAQ Companies - March 14, 2024Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business UpdateInitial proof of concept data from Phase 1a trial evaluating ELVN-001 in adults with chronic myeloid leukemia (CML) is expected […]Read More
0 NASDAQ Companies - March 14, 2024Zumiez Inc. Announces Fiscal 2023 Fourth Quarter ResultsLYNNWOOD, Wash., March 14, 2024 (GLOBE NEWSWIRE) — Zumiez Inc. (NASDAQ: ZUMZ) a leading specialty retailer of apparel, footwear, equipment […]Read More